Stock ROOPAIND6 ROOPA INDUSTRIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Roopa Industries Limited

Equities

ROOPAIND6

INE443C01010

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 05:23:37 2024-07-01 EDT 		5-day change 1st Jan Change
58.65 INR +1.66% Intraday chart for Roopa Industries Limited +2.96% +13.54%
02-12 Roopa Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Roopa Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 109.3 86.05 82.19 73.62 196.6 322.4
Enterprise Value (EV) 1 268.4 235.2 214.8 203.2 301.5 491.7
P/E ratio 20.3 x 14.2 x 22.1 x 10.3 x 19.4 x 23.9 x
Yield - - - - - -
Capitalization / Revenue 0.51 x 0.28 x 0.3 x 0.28 x 0.38 x 0.42 x
EV / Revenue 1.25 x 0.78 x 0.78 x 0.76 x 0.59 x 0.65 x
EV / EBITDA 14.8 x 8.87 x 7.53 x 7.37 x 8.43 x 12.5 x
EV / FCF -5.56 x 24.1 x 13.5 x 100 x 12.3 x -13.8 x
FCF Yield -18% 4.14% 7.43% 1% 8.15% -7.24%
Price to Book 1.11 x 0.83 x 0.76 x 0.64 x 1.56 x 2.31 x
Nbr of stocks (in thousands) 7,866 7,866 7,866 7,866 7,866 7,866
Reference price 2 13.89 10.94 10.45 9.360 25.00 40.99
Announcement Date 9/29/18 9/7/19 12/4/20 9/16/21 9/7/22 9/7/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 214.8 302 276.5 265.8 512.1 761.7
EBITDA 1 18.19 26.5 28.52 27.58 35.74 39.32
EBIT 1 12.94 20.78 20.89 19.47 26.48 30.42
Operating Margin 6.02% 6.88% 7.56% 7.33% 5.17% 3.99%
Earnings before Tax (EBT) 1 4.41 7.896 8.001 9.325 13.6 18.07
Net income 1 5.395 6.041 3.72 7.162 10.15 13.49
Net margin 2.51% 2% 1.35% 2.69% 1.98% 1.77%
EPS 2 0.6859 0.7681 0.4730 0.9106 1.290 1.716
Free Cash Flow 1 -48.28 9.746 15.95 2.033 24.57 -35.58
FCF margin -22.47% 3.23% 5.77% 0.76% 4.8% -4.67%
FCF Conversion (EBITDA) - 36.78% 55.94% 7.37% 68.73% -
FCF Conversion (Net income) - 161.32% 428.83% 28.38% 242.05% -
Dividend per Share - - - - - -
Announcement Date 9/29/18 9/7/19 12/4/20 9/16/21 9/7/22 9/7/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 159 149 133 130 105 169
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 8.748 x 5.628 x 4.65 x 4.699 x 2.932 x 4.305 x
Free Cash Flow 1 -48.3 9.75 16 2.03 24.6 -35.6
ROE (net income / shareholders' equity) 5.63% 5.97% 3.51% 6.41% 8.41% 10.2%
ROA (Net income/ Total Assets) 2.52% 3.62% 3.5% 2.88% 3.47% 3.6%
Assets 1 214.5 167 106.3 248.7 292.4 374.7
Book Value Per Share 2 12.50 13.30 13.70 14.70 16.00 17.70
Cash Flow per Share 2 0.0700 0.2200 0.3200 0.6400 1.900 2.470
Capex 1 24.2 26.8 5 7.42 8.43 13.7
Capex / Sales 11.27% 8.87% 1.81% 2.79% 1.65% 1.8%
Announcement Date 9/29/18 9/7/19 12/4/20 9/16/21 9/7/22 9/7/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ROOPA INDUSTRIES LIMITED Stock Roopa Industries Limited
+13.54% 5.44M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.36% 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.09% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.09% 224B
NOVARTIS AG Stock Novartis AG
+13.16% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ROOPAIND6 Stock
  4. Financials Roopa Industries Limited